Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3: A promising therapeutic target for autoimmune diseases
Hui‐Hui Shen, Yuexin Yang, Xiang Meng, et al.
Autoimmunity Reviews (2018) Vol. 17, Iss. 7, pp. 694-702
Closed Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Pyroptosis: mechanisms and diseases
Pian Yu, Xu Zhang, Nian Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Focus on the Role of NLRP3 Inflammasome in Diseases
Roberta Fusco, Rosalba Siracusa, Tiziana Genovese, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4223-4223
Open Access | Times Cited: 230
NLRP3 inflammasome activation triggers gasdermin D–independent inflammation
Chun Wang, Tong Yang, Jianqiu Xiao, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 185
Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
Jianan Zhao, Ping Jiang, Shicheng Guo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 161
Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
Qi Lv, Xing Yao, Jian Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 9, pp. 2880-2899
Open Access | Times Cited: 148
Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: Potential role in Sjögren’s syndrome
María‐José Barrera, Sergio Aguilera, Isabel Castro, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 8, pp. 102867-102867
Closed Access | Times Cited: 141
Microglial PGC-1α protects against ischemic brain injury by suppressing neuroinflammation
Bin Han, Wei Jiang, Pan Cui, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 138
SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
Pan Shen, Xuan Deng, Zhe Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 109
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175091-175091
Closed Access | Times Cited: 106
Regulation of Inflammation in Autoimmune Disease
Lihua Duan, Xiaoquan Rao, Keshav Raj Sigdel
Journal of Immunology Research (2019) Vol. 2019, pp. 1-2
Open Access | Times Cited: 126
Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
Danbin Wu, Yefei Chen, Yingxin Sun, et al.
Inflammation (2019) Vol. 43, Iss. 1, pp. 17-23
Closed Access | Times Cited: 125
Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome
Maomao Zhang, Zheng Yang, Yong Sun, et al.
Theranostics (2019) Vol. 9, Iss. 12, pp. 3425-3442
Open Access | Times Cited: 113
The IL-1 family cytokines and receptors in autoimmune diseases
Paola Migliorini, Paola Italiani, Federico Pratesi, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 9, pp. 102617-102617
Closed Access | Times Cited: 113
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review
Jae Il Shin, Keum Hwa Lee, Yo Han Joo, et al.
Journal of Autoimmunity (2019) Vol. 103, pp. 102299-102299
Closed Access | Times Cited: 100
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Bo‐Zong Shao, Qi Cao, Liu Chong
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 95
Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
Carolina Pellegrini, Matteo Fornai, Luca Antonioli, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2876-2876
Open Access | Times Cited: 89
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
Qiuling Chen, Haoran Yin, Qing‐Yu He, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111442-111442
Open Access | Times Cited: 86
P2X7 receptor: A potential therapeutic target for autoimmune diseases
Fan Cao, Liqin Hu, Shu-Ran Yao, et al.
Autoimmunity Reviews (2019) Vol. 18, Iss. 8, pp. 767-777
Closed Access | Times Cited: 81
Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI
Yuhua Chen, Jiao Meng, Quanhua Xu, et al.
Brain Research (2019) Vol. 1710, pp. 163-172
Closed Access | Times Cited: 79
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
Jianhang Jiao, Guanjie Zhao, Yang Wang, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 75
Celastrol inhibits rheumatoid arthritis through the ROS-NF-κB-NLRP3 inflammasome axis
Ming Jing, Junjie Yang, Lirong Zhang, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107879-107879
Closed Access | Times Cited: 66
The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
Dexter Puckett, Mohammed Alquraishi, Winyoo Chowanadisai, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1171-1171
Open Access | Times Cited: 62
Emerging pyroptosis-engineered nanobiotechnologies regulate cancers and inflammatory diseases: A double-edged sword
Yan Zhang, Chao Fang, Wei Zhang, et al.
Matter (2022) Vol. 5, Iss. 11, pp. 3740-3774
Closed Access | Times Cited: 61
TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia
Yahui Zhang, Baohua Hou, Peiyu Liang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 59
Role of NLRP3 Inflammasome in Rheumatoid Arthritis
Hui Yin, Na Liu, Keshav Raj Sigdel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top